Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2825 of 3546 entries
View as:

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01999842 Org: User:
Start: 11/25/13 End: 01/19/15 Due: 01/19/16

Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study.

Phase: N/A Priority: Normal
NCT ID: NCT01899638 Org: User:
Start: 05/20/13 End: 07/25/13 Due: 07/25/14

A Drug Interaction Study With Fluticasone Furoate/GW642444 Inhalation Powder and Ketoconazole

Phase: N/A Priority: Normal
NCT ID: NCT01165125 Org: User:
Start: 07/01/10 End: 08/28/10 Due: 08/28/11

A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT02311881 Org: User:
Start: 01/31/15 End: 02/29/16 Due: 02/28/17

Study Of Atopic Dermatitis In Pediatrics

Phase: N/A Priority: Normal
NCT ID: NCT00257569 Org: User:
Start: 08/31/05 End: - Due: -

Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00329576 Org: User:
Start: 05/31/06 End: 08/31/06 Due: 08/31/07

Safety of Herpes Zoster Subunit (HZ/su) Vaccine During Pregnancy in Adult Women With Immunocompromised Conditions

Phase: N/A Priority: Normal
NCT ID: NCT05811754 Org: User:
Start: 04/03/23 End: 04/30/29 Due: 04/30/30

Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT00460655 Org: User:
Start: 05/31/07 End: 12/31/08 Due: 12/31/09

Safety, Pharmacokinetics (PK) of AKT and MEK Combination

Phase: N/A Priority: Normal
NCT ID: NCT01138085 Org: User:
Start: 05/04/10 End: 11/19/14 Due: 11/19/15

A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01658605 Org: User:
Start: 02/28/13 End: 12/31/14 Due: 12/31/15

Post-operative Dental Pain Study Comparing Analgesic Efficacy

Phase: N/A Priority: Normal
NCT ID: NCT01082081 Org: User:
Start: 10/31/09 End: 03/31/10 Due: 03/31/11

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06256588 Org: User:
Start: 03/21/24 End: 07/13/29 Due: 07/13/30

Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule

Phase: N/A Priority: Normal
NCT ID: NCT00289718 Org: User:
Start: 11/01/04 End: 03/02/05 Due: 03/02/06

A Study of 3 Lots of an Investigational Vaccine Against Respiratory Syncytial Virus (RSV) in Adults Aged 60 Years and Above

Phase: N/A Priority: Normal
NCT ID: NCT05059301 Org: User:
Start: 10/01/21 End: 06/30/22 Due: 06/30/23

A Study to Test the Possibility of Cross Reaction Induced by the Idursulfase Drug to GSK2788723

Phase: N/A Priority: Normal
NCT ID: NCT01602601 Org: User:
Start: 04/09/12 End: 06/11/12 Due: 06/11/13

Ropinirole Tablets In Young Patients With Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00140712 Org: User:
Start: 06/10/05 End: 02/28/08 Due: 02/28/09

A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01018017 Org: User:
Start: 03/03/10 End: 12/25/10 Due: 12/25/11

A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202

Phase: N/A Priority: Normal
NCT ID: NCT06062420 Org: User:
Start: 11/14/23 End: 05/14/27 Due: 05/14/28

GSK1349572 First Time in Human Study

Phase: N/A Priority: Normal
NCT ID: NCT00555035 Org: User:
Start: 11/30/07 End: 02/29/08 Due: 02/28/09

An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02783300 Org: User:
Start: 08/30/16 End: 08/30/23 Due: 08/30/24

A Study of Belantamab Mafodotin to Investigate Safety, Tolerability, Pharmacokinetics, Immunogenicity and Clinical Activity in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

Phase: N/A Priority: Normal
NCT ID: NCT04177823 Org: User:
Start: 12/09/19 End: 12/30/21 Due: 12/30/22

28 Day Repeat Dose in Cystic Fibrosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00903201 Org: User:
Start: 09/28/09 End: 12/29/10 Due: 12/29/11

CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

Phase: N/A Priority: Normal
NCT ID: NCT00479739 Org: User:
Start: 11/30/02 End: 07/31/04 Due: 07/31/05

Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors

Phase: N/A Priority: Normal
NCT ID: NCT00471588 Org: User:
Start: 08/31/06 End: 12/31/07 Due: 12/31/08

A Dose-ranging Study of Fluticasone Furoate (FF)

Phase: N/A Priority: Normal
NCT ID: NCT01563029 Org: User:
Start: 03/28/12 End: 09/24/14 Due: 09/24/15